Clinical Trials Directory

Trials / Completed

CompletedNCT05988047

Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
University of Freiburg · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.

Conditions

Timeline

Start date
2020-05-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2023-08-14
Last updated
2024-05-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05988047. Inclusion in this directory is not an endorsement.